APOG stock news
This page provides real-time market news, earnings updates, and company announcements related to Apogee Enterprises, Inc. (APOG).
All content is aggregated from trusted financial media and market data sources to help investors stay informed about key market movements and corporate developments.
Last updated as of 2026-06-27 06:04 EST
1 Stock to Watch & 1 to Avoid in a Challenging Glass Products Industry
Finviz2026-02-13 17:36:55
End of Apogee (APGE) Drug Collaboration Leads to Revised Analyst Expectations
Finviz2026-02-19 00:42:11
Apogee Therapeutics to Participate in Upcoming March Conferences
Finviz2026-02-24 12:33:44
Apogee Therapeutics Provides Pipeline Progress and Reports Full Year 2025 Financial Results
Finviz2026-03-02 12:03:46
Today's Bullish Patterns & Technical Sentiment | Published on 03/10: APGE, PTGX, BRZE and More
moomoo-证劵2026-03-10 12:48:55
Apogee Therapeutics announced that data results for part B of its APEX study, focusing on the 16-week induction period, are expected to be revealed in the second quarter of 2026.
老虎证券2026-03-23 10:49:59
Apogee Therapeutics, Inc. Announces Proposed $300 Million Underwritten Public Offering
Finviz2026-03-23 20:09:51
Apogee Therapeutics, Inc. Announces Pricing of $350 Million Underwritten Public Offering
Finviz2026-03-25 01:58:01
According to the Financial Times, ongoing negotiations reveal that pharmaceutical giant AbbVie plans to acquire shareholders' equity in biotech company Apogee Therapeutics for a total of $10.9 billion in cash.
老虎证券2026-06-19 14:33:49
US Stocks Pre-market Movement: Apogee surges nearly 53% pre-market amid rumors of a $10.9 billion acquisition by AbbVie
格隆汇2026-06-22 09:42:48
Deutsche Bank raises Apogee target price to 135 USD
格隆汇2026-06-24 07:36:45
Mizuho Securities has adjusted its investment rating for biotechnology company Apogee Therapeutics, downgrading it from "Outperform" to "Neutral"
老虎证券2026-06-24 10:41:38
Today's Bullish Patterns & Technical Sentiment | Published on 03/10: APGE, PTGX, BRZE and More
moomoo-证劵2026-03-10 12:48:55
Apogee Therapeutics announced that data results for part B of its APEX study, focusing on the 16-week induction period, are expected to be revealed in the second quarter of 2026.
老虎证券2026-03-23 10:49:59
Apogee Therapeutics, Inc. Announces Proposed $300 Million Underwritten Public Offering
Finviz2026-03-23 20:09:51
Apogee Therapeutics, Inc. Announces Pricing of $350 Million Underwritten Public Offering
Finviz2026-03-25 01:58:01
According to the Financial Times, ongoing negotiations reveal that pharmaceutical giant AbbVie plans to acquire shareholders' equity in biotech company Apogee Therapeutics for a total of $10.9 billion in cash.
老虎证券2026-06-19 14:33:49
US Stocks Pre-market Movement: Apogee surges nearly 53% pre-market amid rumors of a $10.9 billion acquisition by AbbVie
格隆汇2026-06-22 09:42:48
Deutsche Bank raises Apogee target price to 135 USD
格隆汇2026-06-24 07:36:45
Mizuho Securities has adjusted its investment rating for biotechnology company Apogee Therapeutics, downgrading it from "Outperform" to "Neutral"
老虎证券2026-06-24 10:41:38
APOG stock chart
APOG stock detailsAPOG stock price change
On the last trading day, APOG stock closed at 42.48 USD, with a price change of 1.24% for the day.
Trade spot stocks (24/7)Trade stock perps (up to 100x leverage)About Bitget
The world's first Universal Exchange (UEX), enabling users to trade not only cryptocurrencies, but also stocks, ETFs, forex, gold, and real-world assets (RWA).
To provide deeper liquidity, a more transparent trading experience, and greater capital efficiency, Bitget officially launched its all-new spot stock product, Bitget Stocks 2.0, on June 2, 2026.
The new product is independently issued by licensed RWA protocol Reality, with Bitget providing strategic support and asset security safeguards. This marks a major upgrade to the stock trading experience.
Bitget is moving stock trading beyond the limits of traditional trading models by fully integrating stock assets into its margin and yield ecosystem.
Learn more